GENECENTRIC Trademark

Trademark Overview


On Wednesday, November 27, 2019, a trademark application was filed for GENECENTRIC with the United States Patent and Trademark Office. The USPTO has given the GENECENTRIC trademark a serial number of 88980283. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by GENECENTRIC THERAPEUTICS, INC.. The GENECENTRIC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical, scientific and pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the pharmaceutical and biotechnology fields; Research and development services in the field of gene expression, namely, cancer biology; Providing medical and scientific research services and information in the field of clinical trials; Research and development services for others, namely, research and development of assays for oncological testing, treatment and diagnostic purposes; Scientific research in the field of genome sequence analysis and reporting; Medical laboratory testing services; Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequ...

General Information


Serial Number88980283
Word MarkGENECENTRIC
Filing DateWednesday, November 27, 2019
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6487493
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesProviding medical, scientific and pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the pharmaceutical and biotechnology fields; Research and development services in the field of gene expression, namely, cancer biology; Providing medical and scientific research services and information in the field of clinical trials; Research and development services for others, namely, research and development of assays for oncological testing, treatment and diagnostic purposes; Scientific research in the field of genome sequence analysis and reporting; Medical laboratory testing services; Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 5, 2019
Primary Code042
First Use Anywhere DateTuesday, May 31, 2011
First Use In Commerce DateTuesday, May 31, 2011

Trademark Owner History


Party NameGENECENTRIC THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Party NameGENECENTRIC THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Party NameGENECENTRIC THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events


Event DateEvent Description
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 10, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 9, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021SU - NON-FINAL ACTION - WRITTEN
Thursday, January 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 28, 2020USE AMENDMENT FILED
Thursday, January 21, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, October 28, 2020DIVISIONAL REQUEST RECEIVED
Thursday, January 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 28, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 28, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 27, 2020ASSIGNED TO LIE
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 17, 2019ASSIGNED TO EXAMINER
Thursday, December 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 30, 2019NEW APPLICATION ENTERED IN TRAM